Aldeyra Therapeutics, Inc. ALDX
Set alert
0.56 USD -0.10 -14.99%
At close · Oct 30
0.56 0.00 -0.05%
After hours · Oct 30, 4:14 PM ET
0.5502 Day range 0.68
0.5603 52-week range 5.62
- YTD
- -89.18%
- 1 year
- -88.86%
- Open
- 0.67
- Prev close
- 0.6591
- Mkt cap
- 33.80M
- Vol
- 896.63K
- Avg vol
- 1.15M
- EPS
- -0.38
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.5502
- High
- 0.68
- Forward P/E
- -7.80
- Beta
- 1.43
- Short ratio
- 6.19
- Inst. own
- 62.19%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Oct 3, 2024
- 50-d avg
- 5.12
- 200-d avg
- 4.48
- 1y target
- 10.00
Financial health
Altman Z-Score
-12.96 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 4
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 2
Valuation
P/E -9.2×
FY 2016 5y median -5.5× FY 2025
P/S 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 7.0×
FY 2016 5y median 2.7× FY 2025
P/FCF -9.3×
FY 2016 5y median -6.9× FY 2025
EV/EBITDA -8.1×
FY 2016 5y median -4.6× FY 2025
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -10.7%
FY 2016 5y median -14.6% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -76.5%
FY 2016 5y median -41.1% FY 2025
ROIC -59.0%
FY 2016 5y median -37.5% FY 2025
ROA -47.0%
FY 2016 5y median -34.2% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2025
Operating Income 41.3%
FY 2016 FY 2025
EPS (diluted) 40.4%
FY 2016 FY 2025
Free Cash Flow 22.8%
FY 2016 FY 2025
Financial Health
Current Ratio 2.6×
FY 2016 5y median 6.6× FY 2025
Quick Ratio 2.6×
FY 2016 5y median 6.6× FY 2025
Debt / Equity 0.4×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 1.7×
FY 2016 5y median 2.1× FY 2025
Interest Coverage -18.5×
FY 2016 5y median -31.2× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31